MRSA tracking software for infection prevention teams and what to count
Three different MRSA numbers get called the MRSA rate. A worked example shows how each one is built, which tool produces it, and where a $249 antibiogram plan fits.
7 min read
MRSA tracking software has to produce three different numbers, and most hospitals mix them up: the MRSA share of Staphylococcus aureus isolates, the count of hospital-onset MRSA bloodstream events, and the screening or colonization rate. Only the first comes from a laboratory susceptibility export, and it is the one an antibiogram tool such as Antimicrobe produces from a CSV without an interface.
This is written for the infection preventionist or stewardship pharmacist who is asked for MRSA trends and has to decide what to buy. It separates what each tool does, with a worked example, so you do not pay for surveillance software when the committee only asked for a table.
The three MRSA numbers
| Number | Source data | Tool that produces it |
|---|---|---|
| MRSA share of S. aureus isolates, by unit and year | Lab susceptibility export | Antibiogram software |
| Hospital-onset MRSA bloodstream events per 10,000 patient days | Blood cultures, admission dates, patient days | Infection surveillance system and NHSN reporting |
| Admission screening positivity | Nares PCR or culture screens | Infection control system or LIS report |
A worked example with 384 S. aureus isolates
Take a year of S. aureus results from a 200 bed community hospital: 384 rows. After keeping the first isolate per patient, as CLSI M39 asks, 301 remain. Of those, 118 are oxacillin or cefoxitin resistant. The MRSA share is 118 / 301 = 39.2 percent. Counting every row instead, with repeats from long stays, might give 164 MRSA of 384, or 42.7 percent. Same hospital, 3.5 points apart, and the second figure drifts upward each time a chronic wound patient is recultured.
Now split the 118 by unit. If 52 come from skin and soft tissue cultures in the emergency department and 14 from blood, the useful next table is clindamycin, trimethoprim-sulfamethoxazole and doxycycline susceptibility for those MRSA isolates. That is what decides the oral option for an abscess, and the unit and source filters produce it without rebuilding anything. The numbers here are illustrative arithmetic, not data from a customer.
When an antibiogram tool is enough
If your committee asks for MRSA trends, an annual cumulative antibiogram, or the MRSA and MSSA susceptibility tables behind empiric choices, you do not need a surveillance platform. You need first isolate logic, the 30 isolate rule and unit cuts. If you must report hospital-onset bloodstream events to NHSN, that work lives in your infection control system and the CDC defines the event rules in the NHSN MDRO and CDI module.
What to ask any vendor
- Does it count first isolate per patient, and is the rule printed on the report
- Can it split MRSA and MSSA and show drug susceptibility for each
- Does it need an interface to the LIS or EHR, and who builds it
- Can it cut by unit, source and quarter without a new report request
- What is the price, in writing, before a demo
How this fits with a cumulative antibiogram
Antimicrobe builds the MRSA share and the per drug tables from a susceptibility CSV. See MRSA antibiogram software for the report layout, the hospital antibiogram page for the cumulative table, and MDRO surveillance software for community hospitals if you also track ESBL, CRE and VRE. For the NHSN event definitions see the CDC NHSN MDRO and CDI module.
Related on this site: MRSA antibiogram software, ESBL antibiogram software, antibiogram software cost route by route.